These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Inhibition of mycobacterial replication by pyrimidines possessing various C-5 functionalities and related 2'-deoxynucleoside analogues using in vitro and in vivo models. Srivastav NC; Rai D; Tse C; Agrawal B; Kunimoto DY; Kumar R J Med Chem; 2010 Aug; 53(16):6180-7. PubMed ID: 20718497 [TBL] [Abstract][Full Text] [Related]
7. The synthesis and antituberculosis activity of 5'-nor carbocyclic uracil derivatives. Matyugina E; Khandazhinskaya A; Chernousova L; Andreevskaya S; Smirnova T; Chizhov A; Karpenko I; Kochetkov S; Alexandrova L Bioorg Med Chem; 2012 Nov; 20(22):6680-6. PubMed ID: 23062712 [TBL] [Abstract][Full Text] [Related]
8. Investigation of C-5 alkynyl (alkynyloxy or hydroxymethyl) and/or N-3 propynyl substituted pyrimidine nucleoside analogs as a new class of antimicrobial agents. Garg S; Shakya N; Srivastav NC; Agrawal B; Kunimoto DY; Kumar R Bioorg Med Chem; 2016 Nov; 24(21):5521-5533. PubMed ID: 27665179 [TBL] [Abstract][Full Text] [Related]
9. Facile transformation of Biginelli pyrimidin-2(1H)-ones to pyrimidines. In vitro evaluation as inhibitors of Mycobacterium tuberculosis and modulators of cytostatic activity. Singh K; Singh K; Wan B; Franzblau S; Chibale K; Balzarini J Eur J Med Chem; 2011 Jun; 46(6):2290-4. PubMed ID: 21450375 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and mycobacterial evaluation of 5-substituted-6-acetyl-2-amino-7-methyl-5,8-dihydropyrido-[2,3-d]pyrimidin-4(3H)-one derivatives. Agre N; Degani M; Gupta A; Bhakta S; Ray MK Arch Pharm (Weinheim); 2019 Sep; 352(9):e1900068. PubMed ID: 31339194 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of Mycobacterium tuberculosis strains H37Rv and MDR MS-115 by a new set of C5 modified pyrimidine nucleosides. Shmalenyuk ER; Chernousova LN; Karpenko IL; Kochetkov SN; Smirnova TG; Andreevskaya SN; Chizhov AO; Efremenkova OV; Alexandrova LA Bioorg Med Chem; 2013 Sep; 21(17):4874-84. PubMed ID: 23891229 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis of benzocoumarin-pyrimidine hybrids as novel class of antitubercular agents, their DNA cleavage and X-ray studies. Reddy DS; Hosamani KM; Devarajegowda HC Eur J Med Chem; 2015 Aug; 101():705-15. PubMed ID: 26210508 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents. Shiva Raju K; AnkiReddy S; Sabitha G; Siva Krishna V; Sriram D; Bharathi Reddy K; Rao Sagurthi S Bioorg Med Chem Lett; 2019 Jan; 29(2):284-290. PubMed ID: 30497913 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimycobacterial evaluation of various 6-substituted pyrazolo[3,4-d]pyrimidine derivatives. Trivedi A; Vaghasiya S; Dholariya B; Dodiya D; Shah V J Enzyme Inhib Med Chem; 2010 Dec; 25(6):893-9. PubMed ID: 21054238 [TBL] [Abstract][Full Text] [Related]
15. 3H-1,2,4-Dithiazol-3-one compounds as novel potential affordable antitubercular agents. Yang J; Pi W; Xiong L; Ang W; Yang T; He J; Liu Y; Chang Y; Ye W; Wang Z; Luo Y; Wei Y Bioorg Med Chem Lett; 2013 Mar; 23(5):1424-7. PubMed ID: 23337602 [TBL] [Abstract][Full Text] [Related]
16. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies. Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents. Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631 [TBL] [Abstract][Full Text] [Related]
18. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles. Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766 [TBL] [Abstract][Full Text] [Related]
19. Novel pyrimidine-1,3,4-oxadiazole hybrids and their precursors as potential antimycobacterial agents. Pflégr V; Stolaříková J; Pál A; Korduláková J; Krátký M Future Med Chem; 2023 Jun; 15(12):1049-1067. PubMed ID: 37555280 [No Abstract] [Full Text] [Related]
20. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis. Shakya N; Srivastav NC; Desroches N; Agrawal B; Kunimoto DY; Kumar R J Med Chem; 2010 May; 53(10):4130-40. PubMed ID: 20420370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]